TreeWAS – Variant ID: rs2675399

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G50.0 Trigeminal neuralgia	0.055	0.945	0.000
G50 Disorders of trigeminal nerve	0.021	0.978	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.980	0.020
G50.1 Atypical facial pain	0.016	0.984	0.000
G50.9 Disorder of trigeminal nerve, unspecified	0.015	0.985	0.000
G50.8 Other disorders of trigeminal nerve	0.015	0.985	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.985	0.015
J35.0 Chronic tonsillitis	0.013	0.987	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.987	0.013
W25.9 Unspecified place	0.013	0.987	0.000
C82.0 Small cleaved cell, follicular	0.000	0.987	0.013
J35.8 Other chronic diseases of tonsils and adenoids	0.013	0.987	0.000
J35 Chronic diseases of tonsils and adenoids	0.011	0.989	0.000
C82.2 Large cell, follicular	0.000	0.989	0.011
C82.6 Cutaneous follicle centre lymphoma	0.000	0.989	0.011
C82.5 Diffuse follicle centre lymphoma	0.000	0.989	0.011
C82.4 Follicular lymphoma grade IIIb	0.000	0.989	0.011
C82.3 Follicular lymphoma grade IIIa	0.000	0.989	0.011
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.990	0.010
J35.2 Hypertrophy of adenoids	0.009	0.991	0.000
Z95.0 Presence of cardiac pacemaker	0.000	0.991	0.009
K91.4 Colostomy and enterostomy malfunction	0.000	0.991	0.009
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.008	0.992	0.000
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.008	0.992	0.000
Y45.0 Opioids and related analgesics	0.000	0.993	0.007
C90.0 Multiple myeloma	0.007	0.993	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.993	0.007
K91.3 Postoperative intestinal obstruction	0.000	0.993	0.007
W25 Contact with sharp glass	0.007	0.993	0.000
Y42.5 Other oestrogens and progestogens	0.000	0.993	0.007
M48.06 Spinal stenosis (Lumbar region)	0.000	0.993	0.007
K91.1 Postgastric surgery syndromes	0.000	0.994	0.006
Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue	0.000	0.994	0.006
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.006	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.994	0.006
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.994	0.006
W25.2 School, other institution and public administrative area	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.000	0.995	0.005
C44.5 Skin of trunk	0.005	0.995	0.000
C90.2 Plasmacytoma, extramedullary	0.005	0.995	0.000
Y45.5 4-Aminophenol derivatives	0.000	0.995	0.005
J35.1 Hypertrophy of tonsils	0.005	0.995	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.995	0.005
C90 Multiple myeloma and malignant plasma cell neoplasms	0.005	0.995	0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.995	0.005
M48.0 Spinal stenosis	0.000	0.995	0.005
W25.6 Industrial and construction area	0.005	0.995	0.000
W25.5 Trade and service area	0.005	0.995	0.000
W25.1 Residential institution	0.005	0.995	0.000
W25.0 Home	0.005	0.995	0.000
W25.8 Other specified place	0.005	0.995	0.000
W25.7 Farm	0.005	0.995	0.000
W25.4 Street and highway	0.005	0.995	0.000
W25.3 Sports and athletics area	0.005	0.995	0.000
S00.9 Superficial injury of head, part unspecified	0.000	0.995	0.005
M48.09 Spinal stenosis (Site unspecified)	0.000	0.995	0.005
K91.5 Postcholecystectomy syndrome	0.000	0.995	0.005
K74.3 Primary biliary cirrhosis	0.000	0.995	0.005
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.995	0.005
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.995	0.005
Y42.7 Androgens and anabolic congeners	0.000	0.995	0.005
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.995	0.005
Y44 Agents primarily affecting blood constituents	0.000	0.995	0.005
M48.02 Spinal stenosis (Cervical region)	0.000	0.995	0.005
F41.9 Anxiety disorder, unspecified	0.000	0.995	0.005
Y43.4 Immunosuppressive agents	0.000	0.995	0.005
C44.9 Malignant neoplasm of skin, unspecified	0.004	0.996	0.000
Y44.2 Anticoagulants	0.000	0.996	0.004
Y45.4 Antirheumatics	0.000	0.996	0.004
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.996	0.004
Y52 Agents primarily affecting the cardiovascular system	0.000	0.996	0.004
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.996	0.004
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.996	0.004
X62.9 Unspecified place	0.000	0.996	0.004
Y44.5 Thrombolytic drugs	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.996	0.004
Y43 Primarily systemic agents	0.000	0.996	0.004
C90.3 Solitary plasmacytoma	0.004	0.996	0.000
Y42.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
Y42.4 Oral contraceptives	0.000	0.996	0.004
Y42.1 Thyroid hormones and substitutes	0.000	0.996	0.004
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.996	0.004
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.996	0.004
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.996	0.004
Y52.1 Calcium-channel blockers	0.000	0.996	0.004
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.996	0.004
C90.1 Plasma cell leukaemia	0.004	0.996	0.000
Y41.0 Sulphonamides	0.000	0.996	0.004
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.996	0.004
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
Y59 Other and unspecified vaccines and biological substances	0.000	0.996	0.004
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.996	0.004
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.996	0.004
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.996	0.004
W25.09 Contact with sharp glass; Home; During unspecified activity	0.004	0.996	0.000
W25.03 Contact with sharp glass; Home; While engaged in other types of work	0.004	0.996	0.000
W25.18 Contact with sharp glass; Residential institution;While engaged in other specified activities	0.004	0.996	0.000
W25.52 Contact with sharp glass; Trade and service area;While working for income	0.004	0.996	0.000
W25.62 Contact with sharp glass; Industrial and construction area ;While working for income	0.004	0.996	0.000
K86.3 Pseudocyst of pancreas	0.000	0.996	0.004
Y45.1 Salicylates	0.000	0.996	0.004
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
I42.9 Cardiomyopathy, unspecified	0.000	0.996	0.004
M48.04 Spinal stenosis (Thoracic region)	0.000	0.996	0.004
Y47.1 Benzodiazepines	0.000	0.996	0.004
Y58 Bacterial vaccines	0.000	0.996	0.004
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.996	0.004
K86.2 Cyst of pancreas	0.000	0.996	0.004
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.996	0.003
Y44.7 Plasma substitutes	0.000	0.996	0.003
Y44.6 Natural blood and blood products	0.000	0.996	0.003
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.996	0.003
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.996	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.996	0.003
C44.7 Skin of lower limb, including hip	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.003
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.003
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.997	0.003
Y48 Anaesthetics and therapeutic gases	0.000	0.997	0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
K86.9 Disease of pancreas, unspecified	0.000	0.997	0.003
Y42.2 Antithyroid drugs	0.000	0.997	0.003
Y41.5 Antiviral drugs	0.000	0.997	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
Y43.1 Antineoplastic antimetabolites	0.000	0.997	0.003
K74 Fibrosis and cirrhosis of liver	0.000	0.997	0.003
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
B37.0 Candidal stomatitis	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.997	0.003
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
Y41.4 Anthelminthics	0.000	0.997	0.003
Y41.3 Other antiprotozoal drugs	0.000	0.997	0.003
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
Y41.1 Antimycobacterial drugs	0.000	0.997	0.003
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.997	0.003
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.997	0.003
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.997	0.003
Y47.4 Bromine compounds	0.000	0.997	0.003
Y47.3 Paraldehyde	0.000	0.997	0.003
Y47.2 Chloral derivatives	0.000	0.997	0.003
Y47.0 Barbiturates, not elsewhere classified	0.000	0.997	0.003
Y59.3 Immunoglobulin	0.000	0.997	0.003
K86 Other diseases of pancreas	0.000	0.997	0.003
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
Y43.9 Primarily systemic agent, unspecified	0.000	0.997	0.003
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.997	0.003
Y43.6 Enzymes, not elsewhere classified	0.000	0.997	0.003
Y43.5 Acidifying and alkalising agents	0.000	0.997	0.003
Y43.2 Antineoplastic natural products	0.000	0.997	0.003
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.997	0.003
Y52.7 Peripheral vasodilators	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
K12.1 Other forms of stomatitis	0.000	0.997	0.003
Y59.9 Vaccine or biological substance, unspecified	0.000	0.997	0.003
Y59.8 Other specified vaccines and biological substances	0.000	0.997	0.003
Y59.2 Protozoal vaccines	0.000	0.997	0.003
Y59.1 Rickettsial vaccines	0.000	0.997	0.003
Y59.0 Viral vaccines	0.000	0.997	0.003
Y53.4 Other laxatives	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
Y43.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
K12.3 Oral mucositis (ulcerative)	0.000	0.997	0.003
K74.5 Biliary cirrhosis, unspecified	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
I67.9 Cerebrovascular disease, unspecified	0.000	0.997	0.003
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
Y53.7 Emetics	0.000	0.997	0.003
Y53.6 Antidiarrhoeal drugs	0.000	0.997	0.003
Y53.5 Digestants	0.000	0.997	0.003
Y53.3 Saline and osmotic laxatives	0.000	0.997	0.003
Y53.2 Stimulant laxatives	0.000	0.997	0.003
Y53.0 Histamine H2-receptor antagonists	0.000	0.997	0.003
M46.46 Discitis, unspecified (Lumbar region)	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.000	0.997	0.003
Z83.3 Family history of diabetes mellitus	0.000	0.997	0.003
Y50.9 Central nervous system stimulant, unspecified	0.000	0.997	0.003
Y50.8 Other central nervous system stimulants	0.000	0.997	0.003
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.997	0.003
Y50.1 Opioid receptor antagonists	0.000	0.997	0.003
Y50.0 Analeptics	0.000	0.997	0.003
Y58.9 Other and unspecified bacterial vaccines	0.000	0.997	0.003
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.997	0.003
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.997	0.003
Y58.5 Diphtheria vaccine	0.000	0.997	0.003
Y58.4 Tetanus vaccine	0.000	0.997	0.003
Y58.3 Plague vaccine	0.000	0.997	0.003
Y58.2 Cholera vaccine	0.000	0.997	0.003
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.997	0.003
Y58.0 BCG vaccine	0.000	0.997	0.003
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.997	0.003
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
Y55.5 Anticommon cold drugs	0.000	0.997	0.003
Y55.4 Expectorants	0.000	0.997	0.003
Y55.3 Antitussives	0.000	0.997	0.003
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
Y55.0 Oxytocic drugs	0.000	0.997	0.003
I42 Cardiomyopathy	0.000	0.997	0.003
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
K13.0 Diseases of lips	0.000	0.997	0.003
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
Y54.3 Benzothiadiazine derivatives	0.000	0.997	0.003
A08.4 Viral intestinal infection, unspecified	0.000	0.997	0.003
D86.1 Sarcoidosis of lymph nodes	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.997	0.003
K74.0 Hepatic fibrosis	0.000	0.997	0.003
S06.5 Traumatic subdural haemorrhage	0.000	0.997	0.003
Y48.4 Anaesthetic, unspecified	0.000	0.997	0.003
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.000	0.997	0.003
I42.6 Alcoholic cardiomyopathy	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
C44 Other malignant neoplasms of skin	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.000	0.997	0.003
Y56.8 Other topical agents	0.000	0.997	0.003
Y56.7 Dental drugs, topically applied	0.000	0.997	0.003
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
Y56.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
Y56.2 Local astringents and local detergents	0.000	0.997	0.003
Y56.1 Antipruritics	0.000	0.997	0.003
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
T90.4 Sequelae of injury of eye and orbit	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.000	0.997	0.003
Y48.1 Parenteral anaesthetics	0.000	0.997	0.003
Y48.0 Inhaled anaesthetics	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.001	0.997	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.003	0.997	0.000
K86.1 Other chronic pancreatitis	0.000	0.997	0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
D86 Sarcoidosis	0.003	0.997	0.000
M18 Arthrosis of first carpometacarpal joint	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.997	0.003
K12 Stomatitis and related lesions	0.000	0.997	0.003
C44.0 Skin of lip	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.000	0.997	0.003
N80.1 Endometriosis of ovary	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.002
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.997	0.002
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.002
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.002
Y51.0 Anticholinesterase agents	0.000	0.997	0.002
Z04.8 Examination and observation for other specified reasons	0.000	0.997	0.003
G59.0 Diabetic mononeuropathy	0.000	0.997	0.003
Y54.9 Mineral salts, not elsewhere classified	0.000	0.997	0.002
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.997	0.002
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.997	0.002
Y54.0 Mineralocorticoids	0.000	0.997	0.002
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.000	0.997	0.002
Y46.7 Anti-Parkinsonism drugs	0.000	0.997	0.002
Y46.5 Valproic acid	0.000	0.997	0.002
Y46.3 Deoxybarbiturates	0.000	0.997	0.002
Y46.1 Oxazolidinediones	0.000	0.997	0.002
Y46.0 Succinimides	0.000	0.997	0.002
Y49.9 Psychotropic drug, unspecified	0.000	0.997	0.002
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.002
Y49.7 Psychostimulants with abuse potential	0.000	0.997	0.002
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.997	0.002
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.002
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.002
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.002
S02.8 Fractures of other skull and facial bones	0.000	0.997	0.003
Y48.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.002
Y48.3 Local anaesthetics	0.000	0.997	0.002
Y54.7 Agents affecting calcification	0.000	0.997	0.002
Y46.4 Iminostilbenes	0.000	0.997	0.002
Y56.3 Emollients, demulcents and protectants	0.000	0.997	0.002
Y57.6 Other diagnostic agents	0.000	0.997	0.002
M46.4 Discitis, unspecified	0.002	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.000	0.997	0.002
I42.8 Other cardiomyopathies	0.000	0.998	0.002
Y46.2 Hydantoin derivatives	0.000	0.998	0.002
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.002	0.998	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.998	0.002
M46.47 Discitis, unspecified (Lumbosacral region)	0.002	0.998	0.000
M10.96 Gout, unspecified (Lower leg)	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y57.4 Pharmaceutical excipients	0.000	0.998	0.002
Y57.3 Alcohol deterrents	0.000	0.998	0.002
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y57.1 Lipotropic drugs	0.000	0.998	0.002
Y57.0 Appetite depressants [anorectics]	0.000	0.998	0.002
Z01.8 Other specified special examinations	0.000	0.998	0.002
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
K12.2 Cellulitis and abscess of mouth	0.000	0.998	0.002
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.998	0.002
I42.5 Other restrictive cardiomyopathy	0.000	0.998	0.002
I42.4 Endocardial fibroelastosis	0.000	0.998	0.002
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.998	0.002
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
Z74.1 Need for assistance with personal care	0.000	0.998	0.002
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.000	0.998	0.002
Y57.5 X-ray contrast media	0.000	0.998	0.002
D45 Polycythaemia vera	0.000	0.998	0.002
M46.49 Discitis, unspecified (Site unspecified)	0.002	0.998	0.000
K12.0 Recurrent oral aphthae	0.000	0.998	0.002
C44.8 Overlapping lesion of skin	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.998	0.002
Z04.9 Examination and observation for unspecified reason	0.000	0.998	0.002
S02.10 Fracture of base of skull (closed)	0.000	0.998	0.002
D07.1 Vulva	0.000	0.998	0.002
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.002	0.998	0.000
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.002	0.998	0.000
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.002	0.998	0.000
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.002	0.998	0.000
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.000	0.998	0.002
X62.0 Home	0.000	0.998	0.002
X62.8 Other specified place	0.000	0.998	0.002
X62.7 Farm	0.000	0.998	0.002
X62.6 Industrial and construction area	0.000	0.998	0.002
X62.5 Trade and service area	0.000	0.998	0.002
X62.4 Street and highway	0.000	0.998	0.002
X62.3 Sports and athletics area	0.000	0.998	0.002
X62.2 School, other institution and public administrative area	0.000	0.998	0.002
X62.1 Residential institution	0.000	0.998	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
M46.42 Discitis, unspecified (Cervical region)	0.002	0.998	0.000
E80.4 Gilbert's syndrome	0.000	0.998	0.002
Y54.5 Other diuretics	0.000	0.998	0.002
Z73.3 Stress, not elsewhere classified	0.000	0.998	0.002
Y54.4 Loop [high-ceiling] diuretics	0.000	0.998	0.002
S02.81 Fractures of other skull and facial bones (open)	0.000	0.998	0.002
C44.2 Skin of ear and external auricular canal	0.002	0.998	0.000
J01.9 Acute sinusitis, unspecified	0.002	0.998	0.000
K86.8 Other specified diseases of pancreas	0.000	0.998	0.002
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
F41.2 Mixed anxiety and depressive disorder	0.000	0.998	0.002
M46.44 Discitis, unspecified (Thoracic region)	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.000	0.998	0.002
C50.1 Central portion of breast	0.000	0.998	0.002
X78.0 Home	0.000	0.998	0.002
Z03.9 Observation for suspected disease or condition, unspecified	0.002	0.998	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.998	0.002
I05.1 Rheumatic mitral insufficiency	0.000	0.998	0.002
Z74.0 Reduced mobility	0.000	0.998	0.002
S70.0 Contusion of hip	0.000	0.998	0.002
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.002	0.998	0.000
Q82.8 Other specified congenital malformations of skin	0.002	0.998	0.000
S06.3 Focal brain injury	0.000	0.998	0.002
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
D05.7 Other carcinoma in situ of breast	0.000	0.998	0.002
D86.9 Sarcoidosis, unspecified	0.002	0.998	0.000
H40.5 Glaucoma secondary to other eye disorders	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.000	0.998	0.002
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.002	0.998	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.002	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.002	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.002	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.002	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.002	0.998	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.002	0.998	0.000
Z04.5 Examination and observation following other inflicted injury	0.000	0.998	0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.000	0.998	0.002
N99.8 Other postprocedural disorders of genito-urinary system	0.002	0.998	0.000
S02.1 Fracture of base of skull	0.000	0.998	0.002
Z74.9 Problem related to care-provider dependency, unspecified	0.000	0.998	0.002
R55 Syncope and collapse	0.000	0.998	0.002
Z74 Problems related to care-provider dependency	0.000	0.998	0.002
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.998	0.002
Z04 Examination and observation for other reasons	0.000	0.998	0.002
J93.8 Other pneumothorax	0.002	0.998	0.000
M18.1 Other primary arthrosis of first carpometacarpal joint	0.002	0.998	0.000
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues	0.000	0.998	0.002
D83 Common variable immunodeficiency	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.998	0.002
C15.9 Oesophagus, unspecified	0.000	0.998	0.002
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.998	0.002
D84 Other immunodeficiencies	0.002	0.998	0.000
F41 Other anxiety disorders	0.000	0.998	0.002
S06 Intracranial injury	0.000	0.998	0.002
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.998	0.002
D35.2 Pituitary gland	0.000	0.998	0.002
J93.0 Spontaneous tension pneumothorax	0.002	0.998	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.998	0.002
R54 Senility	0.000	0.998	0.002
X78 Intentional self-harm by sharp object	0.000	0.998	0.002
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.998	0.001
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.998	0.002
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
J84 Other interstitial pulmonary diseases	0.000	0.998	0.002
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.998	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.998	0.002
K31.1 Adult hypertrophic pyloric stenosis	0.002	0.998	0.000
M10.9 Gout, unspecified	0.000	0.998	0.002
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
Y84.2 Radiological procedure and radiotherapy	0.000	0.998	0.002
Z74.2 Need for assistance at home and no other household member able to render care	0.000	0.998	0.002
D82 Immunodeficiency associated with other major defects	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.000	0.998	0.002
J30.1 Allergic rhinitis due to pollen	0.002	0.998	0.000
I05.0 Mitral stenosis	0.000	0.998	0.002
S02.4 Fracture of malar and maxillary bones	0.000	0.998	0.002
Z74.3 Need for continuous supervision	0.000	0.998	0.001
T90 Sequelae of injuries of head	0.002	0.998	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.002	0.998	0.000
D06.9 Cervix, unspecified	0.002	0.998	0.000
D83.9 Common variable immunodeficiency, unspecified	0.001	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.001	0.998	0.000
T90.8 Sequelae of other specified injuries of head	0.002	0.998	0.000
Z43.1 Attention to gastrostomy	0.000	0.998	0.002
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.998	0.002
S02.11 Fracture of base of skull (open)	0.000	0.998	0.001
I70.0 Atherosclerosis of aorta	0.000	0.998	0.001
Z04.6 General psychiatric examination, requested by authority	0.000	0.998	0.001
Z04.4 Examination and observation following alleged rape and seduction	0.000	0.998	0.001
Z04.2 Examination and observation following work accident	0.000	0.998	0.001
Z04.0 Blood-alcohol and blood-drug test	0.000	0.998	0.001
M10.94 Gout, unspecified (Hand)	0.000	0.998	0.001
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.001
S06.2 Diffuse brain injury	0.000	0.998	0.001
J84.8 Other specified interstitial pulmonary diseases	0.000	0.998	0.001
Q82.0 Hereditary lymphoedema	0.001	0.998	0.000
D83.8 Other common variable immunodeficiencies	0.001	0.998	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.001	0.998	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.001	0.998	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.001	0.998	0.000
S00.5 Superficial injury of lip and oral cavity	0.000	0.998	0.001
S06.7 Intracranial injury with prolonged coma	0.000	0.998	0.001
S06.1 Traumatic cerebral oedema	0.000	0.998	0.001
J93 Pneumothorax	0.002	0.998	0.000
S02 Fracture of skull and facial bones	0.000	0.998	0.002
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.998	0.001
D84.8 Other specified immunodeficiencies	0.001	0.998	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.001	0.998	0.000
X78.9 Unspecified place	0.000	0.998	0.001
X78.8 Other specified place	0.000	0.998	0.001
X78.7 Farm	0.000	0.998	0.001
X78.6 Industrial and construction area	0.000	0.998	0.001
X78.5 Trade and service area	0.000	0.998	0.001
X78.4 Street and highway	0.000	0.998	0.001
X78.3 Sports and athletics area	0.000	0.998	0.001
X78.2 School, other institution and public administrative area	0.000	0.998	0.001
X78.1 Residential institution	0.000	0.998	0.001
Q82 Other congenital malformations of skin	0.001	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.999	0.001
D33.3 Cranial nerves	0.001	0.999	0.000
G31.2 Degeneration of nervous system due to alcohol	0.001	0.999	0.000
J93.1 Other spontaneous pneumothorax	0.001	0.999	0.000
S06.8 Other intracranial injuries	0.000	0.999	0.001
I05 Rheumatic mitral valve diseases	0.000	0.999	0.001
M48 Other spondylopathies	0.000	0.999	0.001
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.999	0.001
M10.98 Gout, unspecified (Other)	0.000	0.999	0.001
M10.95 Gout, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
M10.91 Gout, unspecified (Shoulder region)	0.000	0.999	0.001
D81.9 Combined immunodeficiency, unspecified	0.001	0.999	0.000
D81.8 Other combined immunodeficiencies	0.001	0.999	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.999	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.999	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.999	0.000
D81.4 Nezelof's syndrome	0.001	0.999	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.999	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.999	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.999	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.001	0.999	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.001	0.999	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.001	0.999	0.000
D82.2 Immunodeficiency with short-limbed stature	0.001	0.999	0.000
D82.1 Di George's syndrome	0.001	0.999	0.000
D82.0 Wiskott-Aldrich syndrome	0.001	0.999	0.000
F41.3 Other mixed anxiety disorders	0.000	0.999	0.001
J84.0 Alveolar and parietoalveolar conditions	0.000	0.999	0.001
M06.9 Rheumatoid arthritis, unspecified	0.000	0.999	0.001
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations